ChEBI Mrv0541 04191212142D 22 25 0 0 1 0 999 V2000 16.9197 -13.7280 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 16.9196 -15.5818 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 17.7239 -15.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7240 -13.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2746 -14.2424 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 16.2746 -15.0674 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 15.5602 -14.6549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 16.7692 -14.6346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.4713 -14.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.0819 -14.6549 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 18.9069 -14.6549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.6214 -15.8924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.6214 -15.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 20.3358 -13.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.0503 -13.4174 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 20.3358 -14.6549 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 21.0503 -15.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.7648 -14.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.0503 -15.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.7648 -16.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.4792 -15.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.4792 -15.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 5 1 0 0 0 0 4 1 1 0 0 0 0 5 6 1 0 0 0 0 6 2 1 0 0 0 0 2 3 1 0 0 0 0 3 10 1 0 0 0 0 10 4 1 0 0 0 0 5 7 1 1 0 0 0 6 7 1 1 0 0 0 1 8 1 1 0 0 0 2 8 1 1 0 0 0 8 9 1 0 0 0 0 10 11 1 6 0 0 0 11 13 1 0 0 0 0 13 12 2 0 0 0 0 13 16 1 0 0 0 0 16 14 1 6 0 0 0 14 15 1 0 0 0 0 16 17 1 0 0 0 0 18 17 2 0 0 0 0 17 19 1 0 0 0 0 18 22 1 0 0 0 0 19 20 2 0 0 0 0 20 21 1 0 0 0 0 21 22 2 0 0 0 0 M END > DB00747 > drugbank > CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 > InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1 > STECJAGHUSJQJN-FWXGHANASA-N > C17H21NO4 > 303.3529 > 303.147058165 > 4 > 43 > 0.47327165179743913 > 31.196802239045496 > 1 > 1 > 0 > 1 > (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate > 1.40 > 0.8949522950000002 > -1.66 > 0 > 1 > 4 > 0 > 15.145739865848089 > 6.953523808607151 > 62.3 > 79.72130000000003 > 5 > 1 > 6.61e+00 g/l > tetrahydrofolic acid > 0 > DB00747 > APRD00616 > approved; investigational > Scopolamine > (-)-hyoscine; (-)-scopolamine; (1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate; 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate; 6,7-Epoxytropine tropate; alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester; Hyoscine; scopine (-)-tropate; scopine (−)-tropate; Scopolamine; Scopolamine hydrobromide > Atenolol Scopolamine; B-Donna; Belladonna Alkaloids with Phenobarbital; Belladonna Alkaloids with Phenobartbital; Diban Cap; Donnagel Liq; Donnatal; Donnatal Elixir; Donnatal Extentabs; Donnatal Extentabs Srt; Donnatal Tab; Isopto Hyoscine; Kimite; Me-PB-Hyos; PB Hyos; Phenobarbital With Belladonna Alkaloids; Phenobarbital with Belladonna Alkaloids; Phenobarbital with Belladonna Alkaloids - Grape; Phenobarbital with Belladonna Alkaloids - Mint; Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide; Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide; Phenohytro; Propranolol Scopolamine; Quadrapax; Re-PB Hyos; Re-PB Hyos Elixir; Scopace; Scopolamine; Scopolamine Bromide Trihydrate; Scopolamine Hydrobromide; Scopolamine Hydrobromide Injection; Scopolamine Hydrobromide Injection USP; Scopolamine Trandermal System; Scopolamine Transdermal System; Se-donna Pb Hyos; Servira; Transderm Scop; Vitetal > Scopoderm; Transderm-Scop $$$$